Arcadia Capital Advises InformedDNA on Divestiture of Genetic Testing Utilization Management Business Unit to Zyter
Arcadia Capital Advises InformedDNA on Divestiture of Genetic Testing Utilization Management Business Unit to Zyter
Arcadia Capital, the premier strategic advisor and investment bank to leaders in the tech and tech services ecosystem, served as exclusive financial advisor to InformedDNA ("IDNA" or "the Company"), a portfolio company of Truehelm and QHP Capital, in the divestiture of its Genetic Testing Utilization Management ("GTUM") business unit to Zyter, a subsidiary of Infinite, a global technology company. The transaction marks the Company's continued investment in and focus on DNAimpact, its category-defining precision health platform, and follows the May 2026 divestiture of IDNA's Payment Integrity business unit.
The GTUM unit partners with health plans to bring clinical rigor to one of the fastest-moving categories of medical spend. It pairs genetics-trained specialists with evidence-based review so that members receive the tests that are clinically right for them and payers avoid spend on those that are not. As the volume and complexity of genetic tests on the market compound, that capability has increasingly become essential payer infrastructure.
"Arcadia has been a trusted partner and critical part of our team through both of our divestitures, helping to refine the strategy and running the process. We look forward to our continued working relationship," said Surya Singh, MD, Chief Executive Officer of InformedDNA.
"After deciding to sharpen InformedDNA's focus on using genetic testing for precision health, Arcadia brought our board sharp strategic thinking and disciplined execution to get it done," said Conor Green, Partner at Truehelm and board member of InformedDNA.
The transaction underscores Arcadia Capital's continued leadership in advising high-growth software, SaaS, AI, agentic AI and tech services businesses on strategic transactions. The deal reinforces Arcadia's ability to both strategically advise and efficiently deliver transformative outcomes for founders, operators and financial sponsors.
For media inquiries, please email media@arcadiacapital.io
View source version on businesswire.com: https://www.businesswire.com/news/home/20260818187524/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
4 Stocks to Buy Before They Rise Further
The Top Funds for a Simpler Retirement Portfolio
United States